A Clinical Study Evaluating the Safety and Efficacy of IDP-110 in Patients With Acne Vulgaris

Completed · Phase 3

Conditions studied: Acne Vulgaris

In brief

The purpose of this study is to assess the effectiveness of IDP-110 in treating patients with acne vulgaris.

Key facts

Study ID
NCT00664248
Run by
Dow Pharmaceutical Sciences
People needed
1414
Starts
2006-10-01
Last updated by the study team
2008-04-22

Who can join

Age: 12 and older, up to 70. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.